Atypical Ventures
Venture capitalActively deployingDover
Fund manager profile
Atypical Ventures is a venture fund manager based in Dover. SEC filings show 3 venture funds on record, most recently Atypical Ventures Fund II, LP filed May 2025.
Source: SEC EDGAR Form D filings. Firm website data not yet available.
What they invest in
from 4 of 5 portfolio companiesAI & Machine Learning ×3Healthtech ×3Biotech ×2Wellness & Fitness ×2Consumer ×1Cybersecurity ×1Deep Tech ×1Enterprise Software ×1
HQs:United States×4
Investments · 5 tracked
founders shown can be your intro pathRichmond, US
Amy Brachman(Executive Officer)David Vogeleer(Director)Caribou Honig(Director)Steven Shein(Director)Christopher Wake(Director)Charles Merritt(Executive Officer, Director)
Board seatChristopher Wake· per SEC Form D · $7.2M raise · filed Jan 2024
Twosense uses passive biometrics and machine learning for continuous user authentication in enterprise environments, eliminating the need for passwords and physical tokens.
AI & Machine LearningCybersecurityEnterprise SoftwareHealthtechBrooklyn, US
Dawud Gordon(CEO)John Tanios(Executive Officer, Director)Christopher Wake(Director)
Board seatChristopher Wake· per SEC Form D
Buddy provides embedded insurance technology that allows companies to offer insurance products directly to customers within their digital products or checkout experiences.
AI & Machine LearningInsurTechSaaSWellness & FitnessRichmond, US
Charles Merritt(Co-Founder, CEO)David Vogeleer(Co-Founder, CTO)
Parallel Bio develops human immune organoids and computational tools to predict drug efficacy across diverse patient populations, replacing animal testing in drug discovery.
AI & Machine LearningBiotechDeep TechHealthtechSan Francisco, US
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- Where is Atypical Ventures located?
- Atypical Ventures is headquartered in Dover, US.